Which pharmacy stocks are the hottest right now?
Some of the best-performing stocks in the pharmacy industry are on the rise.
From drug makers to food processors, pharmacy stocks that could benefit from a boom in demand could be worth buying.
Rite Aid (RAI) Rite Aid is a leader in providing health and wellness products for the general public and is an integral part of the company’s strategy for the future.
The company is the fourth-largest pharmacy retailer in the United States, according to Euromonitor, and the third-largest in the world, according a recent report by Euromonitors International.
Rite’s share price is up 18% over the past year and is up over 20% year-to-date.
RiteAid (RAIN) Rite Aid has been growing its pharma business for several years now.
Since 2011, it has been able to take advantage of growth in the healthcare market as well as growing consumer interest in health care services and pharmaceuticals.
The growth in healthcare sales, and increased demand for health care products from consumers, has helped the company to expand its portfolio of products.
The stock has surged over the last year and has nearly doubled its market capitalization.
Lantana (LANT) Lantanas pharmacy brand has been doing quite well over the years, gaining market share in the health and personal care markets.
LANT is now expanding into the home and health care areas.
LENT is the most popular pharmacy brand in the US, and in 2015, it had the fifth-largest sales volume in the U.S. and the fourth largest in Canada.
Lants pharmacy brand is a staple of home and personal health care brands, with more than 50% of all home and private health care product sales in the country, according the company.
The pharmacy brand also has been on a tear lately as well.
Last year, the company reported revenue of $12.2 billion.
Merck (MERK) Merck is one of the largest drug manufacturers in the industry, having been acquired by Pfizer for $US17.2 trillion ($20.7 billion) in 2007.
Merk has been a strong performer in the pharma space since acquiring its largest drugmaker in the 1970s, Pfizer, in the merger.
Merks stock has been soaring since Pfizer acquired Merck in 2015.
Last quarter, the stock increased almost 25% year to date and is expected to rise even more this year.
Rite-Aid (RAD) Rite-A-Rita (RAV) is the fifth largest pharmacy chain in the USA.
The chain’s pharmacy business has grown at a healthy pace for the last several years, thanks to an increase in consumer demand for the drugs.
Since 2009, the chain has grown from 6,600 stores to almost 22,000 stores.
In 2018, the number of stores rose from 7,000 to over 23,000.
Blue Cross/Blue Shield (BLUE) Blue Cross is a specialty health insurance company that has been gaining market shares in the market over the course of the past several years.
Blue has been expanding its health and medical products portfolio over the recent years and has gained market share as well, according Euromoncer.
Blue also has a growing pharmaceutical business, and has been adding to its portfolio since acquiring the rights to a number of new drug classes in 2018.
The acquisition of the rights gave Blue access to new drugs in some of its most popular medicines and to a growing number of generic versions of these drugs.
The consolidation of the business is also contributing to a higher share price for Blue, according Bloomberg.
HealthCare.gov (HCP) The Affordable Care Act (ACA) was a landmark piece of legislation that was passed in 2010 and has created the health insurance marketplaces across the country.
The law established new rules and regulations for employers, insurers, Medicaid programs, and employers to offer health insurance.
The legislation also created the exchanges to facilitate enrollment.
The ACA is one big part of a larger economic recovery, but many have concerns about the impact the law will have on health care costs.
The ACA has also created a lot of uncertainty and uncertainty.
Walgreens (WAGS) Walgills stock is up more than 40% in the last 12 months, but its market cap is more than $6 billion, according data from Morningstar.
Allergan (AGN) Allergen is the world’s largest biopharmaceutical company, and its sales have grown substantially over the year.
The share price of Allergin has been climbing in recent years, but the company has been increasing its focus on the pharmaceutical market, which is growing at a faster rate than the healthcare industry.
Allergens share price has risen by more than 70% over last 12-months and is currently at